期刊
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
卷 177, 期 -, 页码 81-88出版社
ELSEVIER
DOI: 10.1016/j.ejpb.2022.06.006
关键词
Patient centric; Drug development; Drug product design; Target product profile; Acceptability; Medication errors; Effectiveness; Compliance/adherence
Patient-centric drug product design is crucial in the pharmaceutical development process, and it is important to integrate patient needs and perspectives from the beginning and weigh product development decision options accordingly.
The increasing awareness of acceptability and usability of pharmaceutical drug products by the patient as a key quality requirement continues to drive need for integrating patient centric drug product design into the pharmaceutical development process. The complex matrix of multiple drug product related decisions during the early drug development process often limits patient-centric drug product (PCDP) design options in the final commercial drug product development phase. To integrate the specific needs and perspectives of patients into drug development and product design process, a rational approach integrated into the complex development matrix is required from the start and weighs product development decision options accordingly. The aim of this work was to develop a madmap for PCDP design in a multidisciplinary approach that leads to better usability, adherence and acceptance of the drug by patients via early integration into the development matrix. The proposed rational approach is based upon regulatory requirements and lessons learned from pediatric and geriatric drug development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据